Clinical Trial Update: Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

View source ↗

Summary

A Netherlands-based clinical study is currently recruiting relapsing-remitting multiple sclerosis patients to evaluate autologous hematopoietic stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Autologous hematopoietic stem cell transplantation (Autologous hematopoietic stem cell transplantation)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: RECRUITING